Assessment of Depression, Sleep Disorders and Quality of Life in Patients with Fibromyalgia
Objective: The aim of this study was to evaluate depression, sleep disorders (SD) and quality of life (QOL) in patients with fibromyalgia (FM).
Materials and Methods: Eighty patients with FM and 46 healthy women were included. In both groups, widespread pain was evaluated with VAS, the QOL with Fibromyalgia Impact Questionnairre (FIQ), and Beck Depression Inventory (BDI). SD was evaluated with VAS and the hypersomnolence Epworth Sleepiness Scale (ESS).
Results: Mean ages, VAS (sleep), and ESS scores of the patient and control groups were 40.12±9.27 years, 7.27±2.22, 5.33±44.19 and 41.69±10.32 years, 0.71±1.31, 2.52±2.52, respectively. The mean BDI and FIQ scores were 21.77±11.9, 57.45±15.23 and 5.08±3.09, 15.77±11.40, respectively. The differences between groups were significant. Widespread pain and VAS (sleep) scores were significantly correlated with BDI and FIQ scores. The correlation between BDI and FIQ scores was also significant.
Conclusion: In FM, the diversity of symptoms resulting in a continuous seeking for cure disturbs the patients and their close ones,disturbing their social cohesion. The authors believe that psychiatric support for these patients, most of whom are evaluated at outpatient clinics of algology, will be helpful.
Keywords : Depression, sleep disorders, quality of life, fibromyalgia